Transformed Non-Hodgkin Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB15483 | Modified vaccinia ankara | 1 | Recruiting | 1 |
DB12240 | Polatuzumab vedotin | 1 / 2 | Recruiting | 1 |
DB02379 | Beta-D-Glucose | 2 | Active Not Recruiting | 1 |
DB14681 | Cortisone | 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Active Not Recruiting | 1 |
DB00773 | Etoposide | 2 | Active Not Recruiting | 1 |
DB00480 | Lenalidomide | 2 | Recruiting | 1 |
DB00959 | Methylprednisolone | 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB00635 | Prednisone | 2 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 2 | Active Not Recruiting | 1 |
DB14546 | Sulfate ion | 2 | Active Not Recruiting | 1 |
DB15044 | Tafasitamab | 2 | Recruiting | 1 |
DB12887 | Tazemetostat | 2 | Recruiting | 1 |
DB00541 | Vincristine | 2 | Active Not Recruiting | 1 |
DB15035 | Zanubrutinib | 2 | Recruiting | 1 |